Carol Alencar
Project with participation of HC of USP and Santa Casa de SP investigates impacts of medicinal cannabis in 2,500 patients
Project coordinated by Cannect, with participation of a researcher from HC of USP and Santa Casa de São Paulo, gathers data from 2,500 patients to expand evidence on the impacts of medicinal cannabis on human health
Texan Voters Criticize How Authorities Handle Cannabis, Reveals Survey
Survey by the Texas Politics Project indicates disapproval outweighs approval in the evaluation of state policies on cannabis and THC
Cannabis and Video Games: A Duo That Doesn't Always Play on the Same Team
Scientific review questions the relationship between video games and recreational cannabis use, revealing contradictory data and paths still open
USP Study Reveals Effects Against Depression and Neuropathy
Research from USP with an animal model reveals that cannabidiol (CBD) can simultaneously alleviate neuropathic pain and symptoms of depression, showing itself as a promising therapeutic alternative to traditional medications
Planting hemp is betting on the future: experts point out environmental and economic benefits in Deusa Cast
Discover the environmental and economic benefits of hemp cultivation in Brazil with experts from the Cannabis Brazil Institute of Science and Technology in episode #34 of Deusa Cast
Goodbye Hangover! Americans Launch Drinks with Less Alcohol, More Innovation, and Even Cannabis
Find out what the alternative beverage industry report says and see which brands and trends will be booming in 2025!
Weight loss with cannabis? Study highlights potential of THCV in appetite and metabolism control
Compound present in cannabis demonstrates promising therapeutic effects in mucoadhesive strips, regulating appetite, metabolism, and insulin sensitivity
GreennPlus: technology, sustainability, and innovation in the Medicinal Cannabis market
GreennPlus, sponsor of the Brazilian Medicinal Cannabis Congress 2025, is a company that combines innovation, sustainability, and a commitment to quality, reinforcing the importance of safe and effective access to medicinal cannabis in Brazil and worldwide
Justice ensures access to cannabidiol for epilepsy patients in the Federal District
Decision of the TJDFT obliges the local government to maintain the supply of cannabis-based medications, even if not on the SUS list
High doses of LSD may help those living with depression
A new study from the University of Basel rescues an old question with the delicacy of offering shelter: what if the cure lies in the courage to dive deep?
Between Justice and Imprisonment: When Treatment with Cannabis Becomes a Crime
Patients who rely on medicinal cannabis face legal battles and, in many cases, imprisonment. Understand the challenges of access, the legal impacts, and the stories of those fighting for the right to treatment in Brazil.
Bill on medicinal cannabis advances in German Parliament amid technical criticisms
Bill on medicinal cannabis in Germany enters a decisive phase in Parliament and receives warnings from experts about regulatory and implementation challenges
Cronos Group announces acquisition of CanAdelaar B.V. for $67 Million; shares rise
With the purchase of the company, the group expands its presence in the European market and reinforces its strategy in the adult use segment, according to Investing
Cannabis-related crimes drop by 80% in Germany after decriminalization
Official report shows that the decriminalization policy is already yielding significant results, with a historic reduction in offenses related to the plant